Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
Amgen’s Clinical Trial Setback With Colon Cancer Drug, Vectibix
March 23, 2007
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.
More on this
from
Business Week
.
pharmamanufacturing
Amgen's clinical trial of its cancer drug, Vectibix, has also found potential safety issues.
More on this
from
Business Week
.
About the Author
pharmamanufacturing | pharmamanufacturing
Latest from Home
Michael Annino | Shutterstock-AI
Cell and gene therapy manufacturing challenges to persist in 2025
CDMO sector looks to recovery in 2025 amid positive macro, industry trends
Key drugs losing patent protection in 2025
Michael Annino / Shutterstock AI
Going above and beyond
Pittsburgh’s biotech leap
Michael Annino/Shutterstock AI
Pharma’s new age of longevity
Load More Content